Axiom Brain Health and Global Alzheimer’s Platform Foundation Celebrate the Next Chapter in Innovative Research in Tampa
24 janv. 2025 10h29 HE
|
Global Alzheimer’s Platform Foundation®
Tampa, Fla., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Axiom Brain Health (Axiom) and the Global Alzheimer’s Platform Foundation® (GAP) celebrated the next chapter in neurodegenerative research at the...
Biologic Pharmamedical Launches Innovative Functional Beverages for Health, Longevity, and Performance
15 janv. 2025 18h46 HE
|
Biologic Pharmamedical Inc.
ThermoGallate™ is Franco Cavaleri’s innovative technology that boosts thermogenesis, supports weight management, and improves muscle tone naturally.
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform
14 janv. 2025 07h45 HE
|
Firefly Neuroscience, Inc.
KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Firefly Neuroscience Closes on Financing of up to $12.4 Million
31 déc. 2024 09h00 HE
|
Firefly Neuroscience, Inc.
TORONTO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
Aging Technology has a Multiplier Effect Like Investment in Space Technology
09 déc. 2024 07h00 HE
|
Posit Science
WASHINGTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Dr. Henry Mahncke, CEO of Posit Science, the maker of the brain health and fitness app BrainHQ, will address the 6th Annual What’s Next Innovation...
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
14 nov. 2024 17h30 HE
|
Firefly Neuroscience, Inc.
Company successfully listed on Nasdaq under the symbol “AIFF” Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s...
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
07 nov. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
Advancing molecular hydrogen for neurological and mental health disorders Expects its molecular hydrogen product to be ready for use in December 2024 TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) --...
Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event
06 nov. 2024 09h00 HE
|
Firefly Neuroscience, Inc.
TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions...
DiagnaMed Advancing the Medical Potential of Hydrogen
30 oct. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on brain health, announces its...
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25 oct. 2024 16h10 HE
|
Firefly Neuroscience, Inc.
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...